Browse Wiki & Semantic Web

Jump to: navigation, search
Http://dbpedia.org/resource/VOLT-02
  This page has no properties.
hide properties that link here 
  No properties link to this page.
 
http://dbpedia.org/resource/VOLT-02
http://dbpedia.org/ontology/abstract VOLT-02 is a water-soluble conjugate of prVOLT-02 is a water-soluble conjugate of progesterone and a neurosteroid which is under development by Levolta Pharmaceuticals (formerly Voltarra Pharmaceuticals) for the treatment of traumatic brain injury, gynecological disorders, and menstrual disorders. As of March 2017, it is in phase II clinical trials for these indications. The chemical structure of VOLT-02 does not appear to have been released yet.does not appear to have been released yet.
http://dbpedia.org/ontology/class http://dbpedia.org/resource/Neurosteroid + , http://dbpedia.org/resource/Progestogen +
http://dbpedia.org/ontology/wikiPageExternalLink http://www.levoltapharma.com/pipeline/ + , https://adisinsight.springer.com/drugs/800041522 +
http://dbpedia.org/ontology/wikiPageID 57017072
http://dbpedia.org/ontology/wikiPageLength 2757
http://dbpedia.org/ontology/wikiPageRevisionID 1042306239
http://dbpedia.org/ontology/wikiPageWikiLink http://dbpedia.org/resource/Category:Progestogens + , http://dbpedia.org/resource/Category:Pregnanes + , http://dbpedia.org/resource/Category:Experimental_drugs + , http://dbpedia.org/resource/Phases_of_clinical_research + , http://dbpedia.org/resource/Conjugate_%28biochemistry%29 + , http://dbpedia.org/resource/Chemical_structure + , http://dbpedia.org/resource/List_of_progestogen_esters + , http://dbpedia.org/resource/Progesterone_%28medication%29 + , http://dbpedia.org/resource/Category:Drugs_with_undisclosed_chemical_structures + , http://dbpedia.org/resource/Clinical_trial + , http://dbpedia.org/resource/Progestogen + , http://dbpedia.org/resource/Menstrual_disorder + , http://dbpedia.org/resource/Neurosteroid + , http://dbpedia.org/resource/Category:Neuroprotective_agents + , http://dbpedia.org/resource/Water-soluble + , http://dbpedia.org/resource/Gynecological_disorder + , http://dbpedia.org/resource/List_of_investigational_sex-hormonal_agents + , http://dbpedia.org/resource/Traumatic_brain_injury + , http://dbpedia.org/resource/Category:Neurosteroids + , http://dbpedia.org/resource/List_of_neurosteroids +
http://dbpedia.org/property/class http://dbpedia.org/resource/Neurosteroid + , http://dbpedia.org/resource/Progestogen +
http://dbpedia.org/property/synonyms Progesterone conjugate
http://dbpedia.org/property/wikiPageUsesTemplate http://dbpedia.org/resource/Template:Steroid-stub + , http://dbpedia.org/resource/Template:Nervous-system-drug-stub + , http://dbpedia.org/resource/Template:Progesterone_receptor_modulators + , http://dbpedia.org/resource/Template:Drugbox + , http://dbpedia.org/resource/Template:Reflist +
http://purl.org/dc/terms/subject http://dbpedia.org/resource/Category:Pregnanes + , http://dbpedia.org/resource/Category:Progestogens + , http://dbpedia.org/resource/Category:Neuroprotective_agents + , http://dbpedia.org/resource/Category:Drugs_with_undisclosed_chemical_structures + , http://dbpedia.org/resource/Category:Neurosteroids + , http://dbpedia.org/resource/Category:Experimental_drugs +
http://www.w3.org/ns/prov#wasDerivedFrom http://en.wikipedia.org/wiki/VOLT-02?oldid=1042306239&ns=0 +
http://xmlns.com/foaf/0.1/isPrimaryTopicOf http://en.wikipedia.org/wiki/VOLT-02 +
owl:sameAs https://global.dbpedia.org/id/6AL8L + , http://dbpedia.org/resource/VOLT-02 + , http://www.wikidata.org/entity/Q55636883 +
rdf:type http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject + , http://dbpedia.org/ontology/ChemicalSubstance + , http://www.wikidata.org/entity/Q8386 + , http://dbpedia.org/ontology/Drug +
rdfs:comment VOLT-02 is a water-soluble conjugate of prVOLT-02 is a water-soluble conjugate of progesterone and a neurosteroid which is under development by Levolta Pharmaceuticals (formerly Voltarra Pharmaceuticals) for the treatment of traumatic brain injury, gynecological disorders, and menstrual disorders. As of March 2017, it is in phase II clinical trials for these indications. The chemical structure of VOLT-02 does not appear to have been released yet.does not appear to have been released yet.
rdfs:label VOLT-02
hide properties that link here 
http://dbpedia.org/resource/VOLT02 + http://dbpedia.org/ontology/wikiPageRedirects
http://dbpedia.org/resource/Progesterone_%28medication%29 + , http://dbpedia.org/resource/List_of_progestogen_esters + , http://dbpedia.org/resource/List_of_investigational_sex-hormonal_agents + , http://dbpedia.org/resource/Progestogen_ester + , http://dbpedia.org/resource/VOLT02 + , http://dbpedia.org/resource/VOLT_02 + http://dbpedia.org/ontology/wikiPageWikiLink
http://en.wikipedia.org/wiki/VOLT-02 + http://xmlns.com/foaf/0.1/primaryTopic
http://dbpedia.org/resource/VOLT-02 + owl:sameAs
 

 

Enter the name of the page to start semantic browsing from.